The Competition Appellate Tribunal (CAT) upheld the ‘s (CCP) finding that Reckitt Benckiser Pakistan Limited engaged in deceptive marketing practices. The company was found guilty of disseminating misleading information about its product, Strepsils, which is registered as a food item and not a medicinal product for sore throat relief.
The Tribunal ordered Reckitt Benckiser to pay a penalty of Rs30 million and comply with the Commission’s corrective measures within the stipulated timeframe. The case was initiated by Square Distribution & Marketing System (Pvt.) Limited after alleging misleading advertising and marketing campaigns regarding Strepsils’ status and characteristics.
Following CCP proceedings, Reckitt Benckiser made significant changes to its product packaging and disclosures, prominently displaying “Non-Medicated” in both English and Urdu. The company is now required to publicize these changes through advertisements in widely circulated newspapers until full compliance is achieved.
To commemorate Pakistan's Independence Day, Bank Alfalah, one of Pakistan's leading commercial banks, partnered with…
In a shared commitment to digital inclusion and rider welfare, foodpanda has signed a Memorandum…
Leading foreign investors continue to demonstrate strong confidence in Pakistan's economic potential, with OICCI member…
Broadway Pizza has opened its 82nd branch on the main road near Hadiabad Society, adjacent…
Lucky Investments Limited ("Lucky Investments") has been awarded AM1, the highest Asset Manager Rating by…
Karachi: Reinforcing its strategic focus on expanding affordable housing finance, particularly for salaried individuals, Meezan…
This website uses cookies.
